Search results
Author(s):
Sofian Johar
,
Nabilah Fadzilah Johani
,
Anne Catherine Cunningham
Added:
1 year ago
BIO-RESORT: 5Y Outcomes
Author(s):
Eline H Ploumen
Added:
2 years ago
Video
Author(s):
Harriette Van Spall
,
Steven E Nissen
Added:
1 year ago
ACC.23/WCC — Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by principal investigator, Dr Steven Nissen (Cleveland Clinic, Cleveland, OH, US) to have a deep dive into the practice-changing CLEAR-Outcomes trial (NCT02993406).The Phase 3 CLEAR-Outcomes trial was conducted to evaluate the impact of bempedoic acid (ETC-1002) on the occurrence of major cardiovascular…
View more
Author(s):
Bruno Scheller
Added:
2 years ago
In this video, Professor Bruno Scheller (Saarland University, Saarbrücken, DE) sits down to discuss the one-year angiographic outcomes of two parallel randomized trials investigating the effectiveness off sirolimus-coated and paclitaxel-coated DCB's in the treatment of coronary in-stent restenosis. Findings suggest comparable outcomes in both devices.
Discussion points:
1. Importance of this…
View more
TCT 23: EVOLUT Low-Risk
Author(s):
Michael J Reardon
Added:
5 months ago
Video
Author(s):
Susheel Kodali
Added:
2 years ago
Dr Susheel Kodali (Columbia University Medical Center, New York, NY, US) discusses the six-month outcomes of the TRISCEND study.Originally presented at TCT 2021, this is a randomized multicenter controlled trial aiming to evaluate the safety and effectiveness of the EVOQUE tricuspid valve replacement system. At 6 months, the results suggest positive outcomes, with a reduction in tricuspid…
View more
Author(s):
Alexander Fanaroff
Added:
1 week ago
CRT 24 - Dr Alexander Fanaroff (Penn Medicine, US) joins us in this short interview to discuss the findings of a national cohort of patients with chronic limb-threatening ischemia, CLIPPER.The CLIPPER cohort includes the baseline data and outcomes of 1.13 million patients with chronic limb-threatening ischemia.Findings from the study showed that for individuals with a diagnosis to limb…
View more
Author(s):
Martin B Leon
Added:
4 months ago
TCT 23 - In this short virtual interview, we are joined by Dr Martin B Leon (Columbia University Medical Center, US) to discuss the 5-year outcomes from Edwards' PARTNER 3 low-risk trial (NCT02675114).PARTNER 3 is a randomized, prospective, multicenter trial that aimed to determine the safety and effectiveness of the SAPIEN 3 transcatheter heart valve in patients with severe calcific aortic…
View more
Author(s):
Kate Wilcox
,
David Preiss
Added:
1 year ago
AHA 22 - Dr Kate Wilcox, CardioNerds Academic Fellow (Medical College of Wisconsin, US) joins us in this collaboration between the @CardioNerds and Radcliffe Cardiology to interview Dr David L Preiss(University of Oxford, UK), investigator of the late-breaking EMPA-Kidney trial (NCT03594110).
The trial, first presented AHA 22, looked at the SGLT2i, empagliflozin's (Boehringer Ingelheim)effect on…
View more
Author(s):
Ajay J Kirtane
Added:
2 years ago
In this short summary interview, Dr. Ajay Kirtane (Columbia University Medical Center, US) shares the six-month outcomes of a randomized trial of renal denervation (RDN) versus a sham procedure for resistant hypertension. The RADIANCE-TRIO Trial, presented first at TCT 2021, showed that the additional effects of pharmacologic intervention with maintenance of a BP-lowering effect of endovascular…
View more